NaV1.1 inhibition can reduce visceral hypersensitivity
Functional bowel disorder patients can suffer from chronic abdominal pain, likely due to visceral hypersensitivity to mechanical stimuli. As there is only a limited understanding of the basis of chronic visceral hypersensitivity (CVH), drug-based management strategies are ill defined, vary considerably, and include NSAIDs, opioids, and even anticonvulsants. We previously reported that the 1.1 subtype of the voltage-gated sodium (NaV; NaV1.1) channel family regulates the excitability of sensory nerve fibers that transmit a mechanical pain message to the spinal cord. Herein, we investigated whether this channel subtype also underlies the abdominal pain that occurs with CVH. We demonstrate that NaV1.1 is functionally upregulated under CVH conditions and that inhibiting channel function reduces mechanical pain in 3 mechanistically distinct mouse models of chronic pain. In particular, we use a small molecule to show that selective NaV1.1 inhibition (a) decreases sodium currents in colon-innervating dorsal root ganglion neurons, (b) reduces colonic nociceptor mechanical responses, and (c) normalizes the enhanced visceromotor response to distension observed in 2 mouse models of irritable bowel syndrome. These results provide support for a relationship between NaV1.1 and chronic abdominal pain associated with functional bowel disorders.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2018 |
---|---|
Erschienen: |
2018 |
Enthalten in: |
Zur Gesamtaufnahme - volume:3 |
---|---|
Enthalten in: |
JCI insight - 3(2018), 11 vom: 07. Juni |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Salvatierra, Juan [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 28.10.2019 Date Revised 06.03.2020 published: Electronic-eCollection Citation Status MEDLINE |
---|
doi: |
10.1172/jci.insight.121000 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM285201719 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM285201719 | ||
003 | DE-627 | ||
005 | 20231225044921.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2018 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1172/jci.insight.121000 |2 doi | |
028 | 5 | 2 | |a pubmed24n0950.xml |
035 | |a (DE-627)NLM285201719 | ||
035 | |a (NLM)29875317 | ||
035 | |a (PII)121000 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Salvatierra, Juan |e verfasserin |4 aut | |
245 | 1 | 0 | |a NaV1.1 inhibition can reduce visceral hypersensitivity |
264 | 1 | |c 2018 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.10.2019 | ||
500 | |a Date Revised 06.03.2020 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Functional bowel disorder patients can suffer from chronic abdominal pain, likely due to visceral hypersensitivity to mechanical stimuli. As there is only a limited understanding of the basis of chronic visceral hypersensitivity (CVH), drug-based management strategies are ill defined, vary considerably, and include NSAIDs, opioids, and even anticonvulsants. We previously reported that the 1.1 subtype of the voltage-gated sodium (NaV; NaV1.1) channel family regulates the excitability of sensory nerve fibers that transmit a mechanical pain message to the spinal cord. Herein, we investigated whether this channel subtype also underlies the abdominal pain that occurs with CVH. We demonstrate that NaV1.1 is functionally upregulated under CVH conditions and that inhibiting channel function reduces mechanical pain in 3 mechanistically distinct mouse models of chronic pain. In particular, we use a small molecule to show that selective NaV1.1 inhibition (a) decreases sodium currents in colon-innervating dorsal root ganglion neurons, (b) reduces colonic nociceptor mechanical responses, and (c) normalizes the enhanced visceromotor response to distension observed in 2 mouse models of irritable bowel syndrome. These results provide support for a relationship between NaV1.1 and chronic abdominal pain associated with functional bowel disorders | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Research Support, U.S. Gov't, Non-P.H.S. | |
650 | 4 | |a Gastroenterology | |
650 | 4 | |a Ion channels | |
650 | 4 | |a Neuroscience | |
650 | 4 | |a Pain | |
650 | 7 | |a NAV1.1 Voltage-Gated Sodium Channel |2 NLM | |
650 | 7 | |a Scn1a protein, mouse |2 NLM | |
650 | 7 | |a Voltage-Gated Sodium Channel Blockers |2 NLM | |
650 | 7 | |a Trinitrobenzenesulfonic Acid |2 NLM | |
650 | 7 | |a 8T3HQG2ZC4 |2 NLM | |
700 | 1 | |a Castro, Joel |e verfasserin |4 aut | |
700 | 1 | |a Erickson, Andelain |e verfasserin |4 aut | |
700 | 1 | |a Li, Qian |e verfasserin |4 aut | |
700 | 1 | |a Braz, Joao |e verfasserin |4 aut | |
700 | 1 | |a Gilchrist, John |e verfasserin |4 aut | |
700 | 1 | |a Grundy, Luke |e verfasserin |4 aut | |
700 | 1 | |a Rychkov, Grigori Y |e verfasserin |4 aut | |
700 | 1 | |a Deiteren, Annemie |e verfasserin |4 aut | |
700 | 1 | |a Rais, Rana |e verfasserin |4 aut | |
700 | 1 | |a King, Glenn F |e verfasserin |4 aut | |
700 | 1 | |a Slusher, Barbara S |e verfasserin |4 aut | |
700 | 1 | |a Basbaum, Allan |e verfasserin |4 aut | |
700 | 1 | |a Pasricha, Pankaj J |e verfasserin |4 aut | |
700 | 1 | |a Brierley, Stuart M |e verfasserin |4 aut | |
700 | 1 | |a Bosmans, Frank |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t JCI insight |d 2016 |g 3(2018), 11 vom: 07. Juni |w (DE-627)NLM257703918 |x 2379-3708 |7 nnns |
773 | 1 | 8 | |g volume:3 |g year:2018 |g number:11 |g day:07 |g month:06 |
856 | 4 | 0 | |u http://dx.doi.org/10.1172/jci.insight.121000 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 3 |j 2018 |e 11 |b 07 |c 06 |